Heesen, C., Kleiter, I., Nguyen, F., Schäffler, N., Kasper, J., Köpke, S., et al. (2010). Risk perception in natalizumab-treated multiple sclerosis patients and their neurologists. Multiple Sclerosis, 16(12), 1507-1512. doi:10.1177/1352458510379819.